{
    "PMC": "2363448",
    "DOI": "10.1054/bjoc.2000.1519",
    "PMID": "11104561",
    "PMCID": "PMC2363448",
    "title": "Screening breast cancer patients for Norwegian ATM mutations.",
    "year": 2000,
    "source_url": "https://europepmc.org/article/PMC/PMC2363448",
    "source": "MED",
    "abstract_text": "483 Norwegian breast cancer patients were screened for six different ataxia telangiectasia mutated (ATM) mutations previously found to account for 83% of the disease alleles in Norwegian ataxia telangiectasia (AT) patients. Only one carrier was found. These results provide no evidence in favour of an excess risk of breast cancer associated with heterozygosity for classical AT mutations, but remain consistent with a maximum 2.4-fold increased risk.",
    "full_text": "pmc Br J Cancer Br J Cancer British Journal of Cancer 0007-0920 1532-1827 Nature Publishing Group 2363448 6691519 10.1054/bjoc.2000.1519 11104561 Regular Article Screening breast cancer patients for Norwegian ATM mutations Laake K 1 Vu P 1 Andersen T I 2 Erikstein B 3 K\u00e5resen R 4 L\u00f8nning P E 5 Skovlund E 6 B\u00f8rresen-Dale A L 1 Department of Genetics, The Norwegian Radium Hospital, Montebello, Oslo, 0310 Department of Oncology, Ullev\u00e5l University Hospital, Oslo, 0407 Department of Oncology, The Norwegian Radium Hospital Department of Surgery, Ullev\u00e5l University Hospital Department of Oncology, Haukeland Hospital, POB 1, Bergen, 5021 Clinical Research Office, The Norwegian Radium Hospital, Norway * E-mail: alb@radium.uio.no 12 2000 83 12 1650 1653 02 12 1999 21 08 2000 06 09 2000 Copyright \u00a9 2000 Cancer Research Campaign 2000 Cancer Research Campaign https://creativecommons.org/licenses/by/4.0/ This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article\u2019s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article\u2019s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/ . 483 Norwegian breast cancer patients were screened for six different ataxia telangiectasia mutated ( ATM ) mutations previously found to account for 83% of the disease alleles in Norwegian ataxia telangiectasia (AT) patients. Only one carrier was found. These results provide no evidence in favour of an excess risk of breast cancer associated with heterozygosity for classical AT mutations, but remain consistent with a maximum 2.4-fold increased risk. \u00a9 2000 Cancer Research Campaign http://www.bjcancer.com ataxia telangiectasia breast neoplasms heterozygote detection polymerase chain reaction breast cancer risk Norwegian founder mutation",
    "full_text_abstract": "483 Norwegian breast cancer patients were screened for six different ataxia telangiectasia mutated ( ATM ) mutations previously found to account for 83% of the disease alleles in Norwegian ataxia telangiectasia (AT) patients. Only one carrier was found. These results provide no evidence in favour of an excess risk of breast cancer associated with heterozygosity for classical AT mutations, but remain consistent with a maximum 2.4-fold increased risk. \u00a9 2000 Cancer Research Campaign http://www.bjcancer.com"
}